Stanford S. Jhee
PAREXEL International (United Kingdom)(GB)PAREXEL International (United States)(US)
Publications by Year
Research Areas
Cholinesterase and Neurodegenerative Diseases, Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Antibiotics Pharmacokinetics and Efficacy, Dementia and Cognitive Impairment Research
Most-Cited Works
- → The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients(2016)410 cited
- → Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor(2011)366 cited
- → The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans(2015)199 cited
- → Pharmacokinetics and Pharmacodynamics of the Triptan Antimigraine Agents(2001)118 cited
- → The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects(2015)109 cited
- → Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting(2012)95 cited